AngioDynamics wins $74.9M in case against biolitec AG AngioDynamics announced a recent court action in its legal case against biolitec AG. On March 18, the U.S. District Court for the District of Massachusetts entered a judgment awarding AngioDynamics $74.9M in damages based on AngioDynamics' claims that biolitec AG, Biomed Technology Holdings Limited and Wolfgang Neuberger tortiously interfered with its U.S. subsidiary, biolitec Inc.'s, contractual obligations. The dispute originally began when AngioDynamics asserted biolitec Inc. breached a contractual agreement to defend and indemnify AngioDynamics against patent infringement claims by third parties arising out of the use of laser vein ablation products supplied by biolitec.
AngioDynamics receives expanded FDA clearance for Celerity Tip location system AngioDynamics' expanded indication for the Celerity tip location system was cleared by the FDA. The new clearance allows for the elimination of a follow-up X-ray when the Celerity system is used to aid in positioning Peripherally Inserted Central Catheters in adults.